Search Results - Gordon Guyatt

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants.

    Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants. by Luciane Cruz Lopes, Frederick A Spencer, Ignacio Neumann, Matthew Ventresca, Shanil Ebrahim, Qi Zhou, Neera Bhatnagar, Sam Schulman, John Eikelboom, Gordon Guyatt

    Published 2014-01-01

    <h4>Background</h4>Patients with atrial fibrillation considering use of anticoagulants must balance stroke reduction against bleeding risk. Knowledge of bleeding risk without the use of anticoagulants may help inform this decision.<h4>Purpose</h4>To determine the rate of majo...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Critical bleeding in adults and children with immune thrombocytopenia: a multicenter cohort study

    Critical bleeding in adults and children with immune thrombocytopenia: a multicenter cohort study by Emily Sirotich, Saifur R. Chowdhury, Dimpy Modi, Gordon Guyatt, Melanie St John, Kerolos Eisa, Adam Cuker, Carolyn E. Beck, Rachael F. Grace, Justin W. Yan, Shuoyan Ning, Charles T. Quinn, Amanda Pfeiffer, Michele P. Lambert, Karen Panckeri, Allyson Pishko, Kristine VanAarsen, Ahmed Slim, Kathryn Carrier, Rebecca Geer, Abinaya Arulselvan, Matthew Basara, Brenna Cannon, Ellis J. Bloom, Sam J. King, Daya Gill, Laura M. Venier, Emily Xu, Ishaq Siddiqui, Bonnie Liu, Timothy Mercier, Taylah Buissereth, Emily M. Harris, Enass H. Raffa, Joel Livingston, Mahmudur Rahman Chowdhury, Maryam Akbari-Moghaddam, Dongyoung Kim, Lehana Thabane, Dena Zeraatkar, Donald M. Arnold

    Published 2025-07-01

    Abstract: Critical bleeding in patients with immune thrombocytopenia (ITP) is a life-threatening hematologic emergency. This study aimed to describe the frequency, management, and outcomes of critical bleeds among adults and children with ITP. We conducted a retrospective cohort study of patients wi...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Reporting guideline for chatbot health advice studies: the Chatbot Assessment Reporting Tool (CHART) statement

    Reporting guideline for chatbot health advice studies: the Chatbot Assessment Reporting Tool (CHART) statement by Elizabeth Loder, Xi Chen, Gordon Guyatt, Per Olav Vandvik, Thomas Agoritsas, Riaz Agha, Xiaoxuan Liu, Yung Lee, Alfonso Iorio, Monica Ortenzi, Michael Mittelman, Joerg Meerpohl, Gary Collins, Michael Berkwits, Annette Flanagin, Nan Liu, Cynthia Lokker, Nipun Verma, Ashirbani Saha, Julio Mayol, Michael Anderson, Hugh Harvey, Eliseo Guallar, Stavros A Antoniou, Melissa McCradden, Piyush Mathur, Xiaomei Yao, Carolyn Canfield, Christine Laine, Stacy Loeb, Timothy Feeney, Gregor Štiglic, Tyler McKechnie, Bright Huo, David Chartash, Jeremy Y Ng, Diana Samuel, Helen Frankish, Karim Ramji, Vanessa Boudreau, Giovanni Cacciamani, Daniela Pacella, Jennifer C Camaradou, Anthony Sunjaya, Arun Thirunavukarasu, An Wen Chan

    Published 2025-08-01

    The Chatbot Assessment Reporting Tool (CHART) is a reporting guideline developed to provide reporting recommendations for studies evaluating the performance of generative artificial intelligence (AI)-driven chatbots when summarising clinical evidence and providing health advice, referred to as chatb...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: